News
Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.
22h
BuzzFeed on MSNPeople Who Have Been Diagnosed With Cancer Are Revealing The "Shocking" Signs You Should Never IgnoreCancer can sadly affect anyone and everyone, and the signs of cancer being present in the body can vary. Recently, Redditor u ...
15h
Refinery29 on MSNWhy Tanning Feels So Complicated For South Asian Women Like MeWelcome to Sun Blocked, Refinery29’s global call to action to wake up to the serious dangers of tanning. No lectures or ...
MDCX ’s lead asset is Skinkject, a patented innovative product intended to address the most commonly occurring cancer, which is skin cancer, or Basal Cell Carcinoma (BCC). Skinject is a thumb-sized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results